Final analysis from an open-label extension study of fenfluramine for the treatment of seizures in Lennox-Gastaut syndrome: long-term impact on patients and caregivers.

Knupp KG, Scheffer IE, Schoonjans AS, Sullivan J, Lagae L, Auvin S, Thiele EA, Guerrini R, Zuberi SM, Nabbout R, Riney K, Nickels KC, Davis R, Lock MD, Dai D, Minh T, Zhang Roper R, Dickson N, Langlois M, Lothe A, Gil-Nagel A